{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:58:56Z","timestamp":1792591136632,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi and Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.diagmicrobio.2022.115651","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T08:10:01Z","timestamp":1643616601000},"page":"115651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2227-6377","authenticated-orcid":false,"given":"Qingyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0298-4851","authenticated-orcid":false,"given":"Nicholas","family":"Neidig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Divoky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5000-1894","authenticated-orcid":false,"given":"Cristian","family":"Lee-Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary","family":"Threatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5769-9807","authenticated-orcid":false,"given":"Rasheda","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7843-2474","authenticated-orcid":false,"given":"Karen","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0001","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jac\/dkv402","article-title":"In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria","volume":"71","author":"Ito","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0002","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/AAC.01695-15","article-title":"In vitro antimicrobial activity of a siderophore cephalosporin, S-649266, against Enterobacteriaceae clinical isolates, including carbapenem-resistant strains","volume":"60","author":"Kohira","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02171-20","article-title":"New perspectives on antimicrobial agents: cefiderocol","volume":"65","author":"McCreary","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0004","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1128\/AAC.01405-16","article-title":"Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against Pseudomonas aeruginosa","volume":"60","author":"Ito","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijantimicag.2018.10.007","volume":"53","author":"Kazmierczak","year":"2019","journal-title":"Intl J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0006","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1128\/AAC.01801-18","article-title":"ARGONAUT-I: Activity of cefiderocol (S-649266), a siderophore cephalosporin, against Gram-negative bacteria, including carbapenem-resistant nonfermenters and Enterobacteriaceae with defined extended-spectrum \u03b2-lactamases and carbapenemases","volume":"63","author":"Jacobs","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0007","unstructured":"Drugs@FDA: FDA-approved drugs. Fetroja (cefiderocol) for injection. Prescribing information. 2022. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/209445s002lbl.pdf"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0008","unstructured":"European Medicines Agency. Fetcroja. Available at: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/fetcroja. 2022"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0009","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0010","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1093\/jac\/dkz354","article-title":"Activity of imipenem\/relebactam against carbapenemase-producing Enterobacteriaceae with high colistin resistance","volume":"74","author":"Carpenter","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0011","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically\u201411th Edition: Approved Standard M07-A11","year":"2018"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0012","series-title":"CLSI supplement M100 ED30","article-title":"Performance standards for antimicrob susceptibility testing","year":"2020"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0013","unstructured":"U. S. Food and Drug Administration. Antibacterial Susceptibility Test Interpretive Criteria. 2022. Available at:https:\/\/www.fda.gov\/drugs\/development-resources\/antibacterial-susceptibility-test-interpretive-criteria?utm_campaign=06262018%20_Notice%20of%20Updates%20%E2%80%93%20FDA%20Recognized%20Antimicrobial%20Susceptibility%20Test%20Interpretive%20Criteria&utm_medium=email&utm_source=Eloqua"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0014","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints \u2013 breakpoints and guidance. 2022. Available at: https:\/\/www.eucast.org\/clinical_breakpoints"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123690","article-title":"The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods","volume":"10","author":"van der Zwaluw","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0016","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/JCM.00193-17","article-title":"Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among Enterobacteriaceae","volume":"55","author":"Pierce","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0017","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1128\/AAC.44.11.3035-3039.2000","article-title":"SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains","volume":"44","author":"Queenan","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0018","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/AAC.04191-14","article-title":"In vitro susceptibility of characterized \u03b2-lactamase-producing strains tested with avibactam combinations","volume":"59","author":"Li","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0019","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1128\/AAC.00425-15","article-title":"Development of a novel real-time PCR assay with high-resolution melt analysis to detect and differentiate OXA-48-like \u03b2-lactamases in carbapenem-resistant Enterobacteriaceae","volume":"59","author":"Hemarajata","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0020","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ja.2016.73","article-title":"In vitro susceptibility of \u03b2-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline","volume":"69","author":"Zhang","year":"2016","journal-title":"J Antibiotics"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0021","unstructured":"National Center for Biotechnology Information. Basic local alignment search tool (BLAST). 2022. Available at: https:\/\/blast.ncbi.nlm.nih.gov\/Blast.cgi"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0022","unstructured":"Expasy. Swiss Bioinformatics Resource Portal. Available at: https:\/\/www.expasy.org. 2022"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0023","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/AAC.34.2.337","article-title":"Outer membrane permeability and \u03b2-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents","volume":"34","author":"Nikaido","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/mBio.03189-19","article-title":"Novel cassette assay to quantify the outer membrane permeability of five \u03b2-lactams simultaneously in carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae","volume":"11","author":"Kim","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01968-17","article-title":"In vitro activity of the siderophore cephalosporin, cefiderocol, against carbapenem-nonsusceptible and multidrug-resistant isolates of Gram-negative bacilli collected worldwide in 2014 to 2016","volume":"62","author":"Hackel","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0026","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1128\/AAC.01454-17","article-title":"In vitro antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against Gram-negative bacteria","volume":"62","author":"Ito","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0027","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.1128\/jb.173.19.5964-5974.1991","article-title":"Evolution of the ferric enterobactin receptor in gram-negative bacteria","volume":"173","author":"Rutz","year":"1991","journal-title":"J Bacteriol"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0028","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1006\/bbrc.1999.1537","article-title":"Overproduction of the outer-membrane proteins FepA and FhuE responsible for iron transport in Escherichia coli hfq::cat mutant","volume":"264","author":"Wachi","year":"1999","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1016\/j.diagmicrobio.2022.115651_bib0029","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1128\/AAC.36.10.2166","article-title":"Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria","volume":"36","author":"Brochu","year":"1992","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889322000190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889322000190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:56:51Z","timestamp":1760003811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889322000190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0732889322000190"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2022.115651","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2022.115651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115651"}}